Chemoinformaics analysis of 14-Oxoheptacosanoic acid
| Molecular Weight | 424.71 | nRot | 25 |
| Heavy Atom Molecular Weight | 372.294 | nRig | 5 |
| Exact Molecular Weight | 424.392 | nRing | 0 |
| Solubility: LogS | -4.677 | nHRing | 0 |
| Solubility: LogP | 5.774 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 82.1692 |
| nHD | 1 | BPOL | 53.9028 |
| QED | 0.381 |
| Synth | 2.847 |
| Natural Product Likeliness | 1.305 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.586 |
| MDCK | 0.00000754 |
| BBB | 0.384 |
| PPB | 0.940852 |
| VDSS | 0.653 |
| FU | 0.0386242 |
| CYP1A2-inh | 0.073 |
| CYP1A2-sub | 0.135 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.065 |
| CYP2c9-sub | 0.983 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.148 |
| CYP3a4-inh | 0.18 |
| CYP3a4-sub | 0.028 |
| CL | 7.953 |
| T12 | 0.764 |
| hERG | 0 |
| Ames | 0.585 |
| ROA | 0.002 |
| SkinSen | 0.972 |
| Carcinogencity | 0.089 |
| EI | 0.985 |
| Respiratory | 0.684 |
| NR-Aromatase | 0.019 |
| Antiviral | No |
| Prediction | 0.607789 |